| 000 | 01639 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250511182024.0 | ||
| 264 | 0 | _c19920722 | |
| 008 | 199207s 0 0 jpn d | ||
| 022 | _a0300-9165 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHirabayashi, K | |
| 245 | 0 | 0 |
_a[Combination chemotherapy with 254-S, ifosfamide and peplomycin for advanced or recurrent cervical cancer]. _h[electronic resource] |
| 260 |
_bNihon Sanka Fujinka Gakkai zasshi _cMar 1992 |
||
| 300 |
_a341-8 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; English Abstract; Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIfosfamide _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aPeplomycin |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aUterine Cervical Neoplasms _xdrug therapy |
| 700 | 1 | _aOkada, E | |
| 700 | 1 | _aNakazuma, Y | |
| 700 | 1 | _aAkamatsu, Y | |
| 700 | 1 | _aSezaki, H | |
| 700 | 1 | _aOhta, M | |
| 700 | 1 | _aNakanishi, Y | |
| 773 | 0 |
_tNihon Sanka Fujinka Gakkai zasshi _gvol. 44 _gno. 3 _gp. 341-8 |
|
| 999 |
_c1383253 _d1383253 |
||